Welcome to the ELIXA clinical research study
Diabetes is a chronic condition affecting approximately 26 million Americans. According to the American Diabetes Association, people with diabetes have a higher-than-average risk of having a heart attack or stroke; these strike people with diabetes more than twice as often as people without diabetes.
People with diabetes and heart disease who have had a recent heart attack or unstable angina have a high risk of having similar events in the future. In general, the higher the level of blood sugar, the greater the risk of future heart attacks and strokes. Sometimes these events can be fatal.
Some large studies have shown that lowering the blood sugar level towards normal will reduce the risk of diabetes-related problems of the eyes, kidneys, and nerves. Many studies also suggest that lowering blood sugar levels towards normal in people with diabetes will also reduce the risk of future cardiovascular events.
ELIXA is a clinical trial that is evaluating if lowering blood sugar with an experimental anti-diabetes medication will prevent future heart attacks and strokes in people with type 2 diabetes who have already experienced a cardiovascular event.
People with diabetes and heart disease who have had a recent heart attack or unstable angina have a high risk of having similar events in the future. In general, the higher the level of blood sugar, the greater the risk of future heart attacks and strokes. Sometimes these events can be fatal.
Some large studies have shown that lowering the blood sugar level towards normal will reduce the risk of diabetes-related problems of the eyes, kidneys, and nerves. Many studies also suggest that lowering blood sugar levels towards normal in people with diabetes will also reduce the risk of future cardiovascular events.
ELIXA is a clinical trial that is evaluating if lowering blood sugar with an experimental anti-diabetes medication will prevent future heart attacks and strokes in people with type 2 diabetes who have already experienced a cardiovascular event.